MARKET WIREReuters • 2h ago
Oil slips more than 1% as talks continue on ending Iran war - ReutersOil slips more than 1% as talks continue on ending Iran war Reuters
Why EYE Stock surged +7.63% Today — RQD Quant Desk Flash
$16.64 +7.63% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $16.84
National Vision Holdings Inc. (EYE) carries a Roarable Rating of C+ (Hold) with 68/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.
ROARABLE C+ • HOLD / WATCH
Cap $1.32B
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on EYE Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is EYE stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-01, National Vision Holdings Inc. (NASDAQ: EYE) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 68/100 at a spot price of $16.64 (+7.63% 1D, market cap $1.32B). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 15/20, Executive Insider Alignment 15/20, FRED Macro Regime Fit 16/20, and SEC Balance-Sheet Forensics 12/20. Across 1016 tracked Health Care issuers, EYE ranks #109 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does EYE compare to STAA and WRBY in the Health Care sector?
▼
Within the Health Care sector (Ophthalmic Goods), EYE carries a Roarable C+ (68/100 RQD), trailing P/E of 44.4x, gross margin of —, and ROIC of 4.4%. By comparison, STAA (STAAR Surgical Company) holds a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $1.27B) and WRBY (Warby Parker Inc.) posts a D+ grade (52/100 RQD, P/E N/A, ROIC -1.7%, cap $3.04B). Among the 5-stock peer group, EYE leads on earnings multiple (44.4x) while EYE leads on capital efficiency (4.4% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for EYE?
▼
Per EYE's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-01-03, CIK 0001710155), National Vision Holdings Inc. generated $1.99B in revenue (+9.0% YoY), $29.6M in net income, and $73.5M in free cash flow against $1.98B in total assets and $223.2M in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Priced at 44x earnings—high expectations leave less room for a lukewarm quarter.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $16.84 (+1.18%)🧬 Cannibal Buyback (-1.24% YoY Shares)⚙️ Cash Engine: 10/20 (D) • 3.7% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 68/100 (C+) historically posted market-perform odds over rolling 90-day windows (+1.8% avg 90D alpha vs SPY • 56.9% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →RQD QUANT TACHOMETERHOLD / WATCH • C+
2-of-3 JEV AI Jury Bullish
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw C · Rk B+
Each axis scored 0–20
12M PRICE TARGET CONE+4.5% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for EYE)Realized 20D OHLCV Swing Band: ±9.7%
Deterministic 5-Pillar Attribution (68/100 Composite)
🔍 WHY EYE SCORES 68/100 (C+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Macro Regime Fit+16/20 pts (24% of score)
FRED Regime × Technicals: 12% of 52W Range • RSI-14 at 45.6 (NEUTRAL RANGE)
▲ #2 Bullish Driver: Whale & Options Positioning+15/20 pts (22% of score)
20D Institutional Volume Accumulation (±9.7% realized swing band)
▼ #1 Drag / Risk Factor: Cash Engine Quality10/20 pts (-10 pt drag)
Capital intensity & 3% operating margin leave 10 pts on the table
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade B+$16.68+4.5% Next Q
76
Q2 (-2Q)Grade B$17.43+7.1% Next Q
73
Q3 (-1Q)Grade B$18.67-10.9% Next Q
71
CurrentGrade C+$16.64+1.8% Hist 90D α
68
Trajectory: B+ (76) → C+ (68)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER
⚔️ Adversarial Opposing Case: Why the EYE Bull Thesis Could Fail
Even with a 68/100 (C+) score, EYE faces multiple-compression risk if 44.4x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
⚠️ Forensic Kill-Switch #1
Priced at 44x earnings—high expectations leave less room for a lukewarm quarter.
⚠️ Forensic Kill-Switch #2
Dilution & Margin Drag: Cannibal Buyback (-1.24% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.
⚠️ Forensic Kill-Switch #3
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($17.04) or 200D SMA ($21.34) invalidates the momentum regime and cuts Target Base ($17.39) toward Bear Floor ($13.56).
🎲 LIVE PREDICTION MARKET ODDS TIED TO $EYE• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “EYE Beats Next Quarter EPS Consensus (Jan 2, 2027) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why EYE Stock surged +7.63% Today — RQD Quant Desk Flash
National Vision Holdings Inc. (EYE) surged +7.63% to $16.64, trading at 12% of its 52-week range ($14.75 – $30.02). Solid steady margins (4% return on capital), mixed timing at 44x P/E—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 12% of its 52-week range ($14.75 – $30.02) with RSI-14 at 45.6 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±9.7% around $16.64 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable C+ (Hold) backed by 52% gross margin and $73.5M annual free cash flow.
Live EYE Headlines & Catalysts
MARKET WIREReuters • 3h ago
Nine people dead in Learjet crash in south Florida, officials say - ReutersNine people dead in Learjet crash in south Florida, officials say Reuters
MARKET WIREReuters • 5h ago
Iran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz - ReutersIran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz Reuters
MARKET WIRECNBC • 7h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
MARKET WIRECNBC • 7h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 8h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 9h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 10h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk
Scheduled RQD Strong Buys & Whale Accumulation Briefing (EYE Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
EYE // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -28.34%📐 HORIZONTAL RANGE
2026-10-30O $16.95H $16.96L $16.22C $16.64VOL 2.42M
RES: $23.89SUP: $14.92SMA50: $17.04SMA200: $21.34
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
EYE Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
33.2%/yr Implied 5Y Growth
vs. +9.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on EYE today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for EYE. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for EYE today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (EYE)
Health Care Rank #109 of 1016
⚔️ STAA vs EYE Full Matrix →
1. Head-to-Head Health Care Peer Comparison (EYE vs. STAA, WRBY, BLCO, RXST)
Industry: Ophthalmic Goods (8 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, National Vision Holdings Inc. (EYE) ranks #109 by composite RQD confidence (68/100, grade C+) and #325 by equity capitalization ($1.32B). Within this direct 5-issuer industry benchmark cohort, EYE leads on earnings valuation at 44.4x trailing P/E, while EYE leads on capital efficiency and profitability with 4.4% ROIC and — gross margin. EYE currently leads its immediate peer cohort in composite quantitative strength at 68/100 (C+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| EYE
ACTIVE
National Vision Holdings Inc. | C+ | 68/100 | 44.4x | — | 4.4% | +7.63% | $1.32B | Benchmark Subject |
| STAA STAAR Surgical Company | D- | 38/100 | — | 76.2% | -35.0% | +2.56% | $1.27B | /staa-vs-eye → |
| WRBY Warby Parker Inc. | D+ | 52/100 | — | 54.0% | -1.7% | +0.66% | $3.04B | /wrby-vs-eye → |
| BLCO Bausch + Lomb Corporation | D- | 42/100 | — | — | 0.8% | 0.00% | $7.29B | /blco-vs-eye → |
| RXST RxSight Inc. | D- | 35/100 | — | 76.6% | -14.9% | +3.06% | $210.0M | /rxst-vs-eye → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2026-01-03 • CIK 0001710155In its most recent audited fiscal period (FY2025, filed 2026-01-03), National Vision Holdings Inc. (EYE) reported GAAP revenue of $1.99B (+9.0% vs. FY2024 revenue of $1.82B , and +13.2% cumulative change since FY2023) , GAAP net income of $29.6M, operating cash flow of $146.3M, and free cash flow of $73.5M (+92.6% YoY). On the balance sheet, EYE closed FY2025 with $1.98B in total assets against $223.2M in total debt (Altman Z-Score: N/A, Piotroski F-Score: 7/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2026-01-03 | $1.99B | $29.6M | $146.3M | $73.5M | $1.98B | $223.2M |
| FY2024 (FY) | 2024-12-28 | $1.82B | -$28.5M | $133.6M | $38.1M | $2.01B | $239.1M |
| FY2023 (FY) | 2023-12-30 | $1.76B | -$65.9M | $173.0M | $173.0M | — | — |
3. EYE Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs EYE stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, National Vision Holdings Inc. (NASDAQ: EYE) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 68/100 at a spot price of $16.64 (+7.63% 1D, market cap $1.32B). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 15/20, Executive Insider Alignment 15/20, FRED Macro Regime Fit 16/20, and SEC Balance-Sheet Forensics 12/20. Across 1016 tracked Health Care issuers, EYE ranks #109 in composite RQD confidence.
How does EYE compare to STAA and WRBY in the Health Care sector?
Within the Health Care sector (Ophthalmic Goods), EYE carries a Roarable C+ (68/100 RQD), trailing P/E of 44.4x, gross margin of —, and ROIC of 4.4%. By comparison, STAA (STAAR Surgical Company) holds a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $1.27B) and WRBY (Warby Parker Inc.) posts a D+ grade (52/100 RQD, P/E N/A, ROIC -1.7%, cap $3.04B). Among the 5-stock peer group, EYE leads on earnings multiple (44.4x) while EYE leads on capital efficiency (4.4% ROIC).
What are the biggest fundamental strengths and SEC risk factors for EYE?
Per EYE's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-01-03, CIK 0001710155), National Vision Holdings Inc. generated $1.99B in revenue (+9.0% YoY), $29.6M in net income, and $73.5M in free cash flow against $1.98B in total assets and $223.2M in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Priced at 44x earnings—high expectations leave less room for a lukewarm quarter.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is EYE trading relative to its 50-day, 200-day, and 52-week technical levels?
EYE last traded at $16.64 (+7.63% on volume of 2,477,415 shares), positioning the stock -2.35% below its 50-day simple moving average ($17.04) and -22.02% below its 200-day simple moving average ($21.34). Across its 52-week range of $14.75 to $30.02, EYE sits at the 12.4% percentile with a 14-day RSI of 45.6 (NEUTRAL RANGE) and an implied next-earnings move of ±9.7% ($15.03 to $18.25).
EYE Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is EYE stock moving today?
Why EYE Stock surged +7.63% Today — RQD Quant Desk Flash. Solid steady margins (4% return on capital), mixed timing at 44x P/E—hold if owned, no rush to chase.